DERM vs HAL · rev $56.1M vs P/E 9.3, $19.05B cap
Journey Medical Corp (DERM) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported DERM revenue for 2024-12-31 was $56.1M. Net income was -$14.7M. Revenue was down 29.1% from 2023-12-31 to 2024-12-31. DERM currently screens at market cap $163.1M.
HAL does not have a complete income-statement cache yet.
DERM currently screens at market cap $163.1M. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the DERM and HAL stock pages for the full models.
Not investment advice.